Use of Micronized Purified Flavonoid Fraction Together with Rivaroxaban Improves Clinical and Ultrasound Outcomes in Femoropopliteal Venous Thrombosis: Results of a Pilot Clinical Trial

INTRODUCTION: The aim of this study was to assess the impact of adding long-term micronized purified flavonoid fraction (MPFF) to standard treatment of femoropopliteal deep vein thrombosis (DVT). METHODS: This pilot, comparative, open-label study with blinded outcome assessor enrolled patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobastov, Kirill, Schastlivtsev, Ilya, Barinov, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318234/
https://www.ncbi.nlm.nih.gov/pubmed/30539384
http://dx.doi.org/10.1007/s12325-018-0849-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318234/
https://www.ncbi.nlm.nih.gov/pubmed/30539384
http://dx.doi.org/10.1007/s12325-018-0849-z

Ejemplares similares